Haleos Labs Limited (NSE:HALEOSLABS)
India
· Delayed Price · Currency is INR 1,278.40
+15.40 (1.22%)
At close: Mar 9, 2026
Haleos Labs Company Description
Haleos Labs Limited engages in the manufacturing of active pharmaceutical ingredients (API) and intermediates in India.
The company offers API and intermediates in areas, such as anti-ulcer, anti-migraine, anti-hypertensive, erectile dysfunction, anti-cancer, antifungal, anti-obesity, anti-emetic, anti-depressant, anti-worm, anti-infective, anti-gout, anti-convulsant, antiviral, and anesthesia, as well as antihistamine, diuretics, hair loss, and ophthalmic API products.
It also exports its products. The company was formerly known as SMS Lifesciences India Limited and changed its name to Haleos Labs Limited in August 2025.
Haleos Labs Limited was founded in 1990 and is based in Hyderabad, India.
Haleos Labs Limited
| Country | India |
| Founded | 1990 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 592 |
| CEO | Talluri Veera Venkata Murthy |
Contact Details
Address: Plot No. 19-III Hyderabad, 500096 India | |
| Phone | 91 40 6628 8888 |
| Website | smslife.in |
Stock Details
| Ticker Symbol | HALEOSLABS |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE320X01016 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Talluri Veera Venkata Satyanarayana Murthy | MD and Executive Director |
| Nadella Rajendra Prasad | Chief Financial Officer and GM of Accounts & Finance |
| Trupti Ranjan Mohanty | Company Secretary and Compliance Officer |
| Talluri Venkata Praveen | Chief Marketing Officer and Executive Director |
| Sudeepthi Gopineedi | Whole-Time Director |
| Lakshminarayana Somisetty | General Manager of Operations |
| Vijay Babu Chirumamilla | Manager of Admin/HR/IT |